Evaluation of efficacy and safety of Immunity Booster Capsules as an Immunity Booster in Adults: A prospective, randomised, double-blind, single center, placebo-controlled, interventional study

Amitojas Wellness Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Male and female subjects aged 18 years and above.
•2. Subjects with general immunodeficiency as determined by the study investigator.
•3. Subjects who are prone to seasonal immunity associated illnesses as determined by the study investigator
•4. Subjects willing to provide informed written consent.

•1. Pregnant, planning to become pregnant or breastfeeding women.
•2. Subjects with significant medical/surgical condition which requires long-term treatment.
•3. Subjects who are currently being treated with other immunostimulant drugs.
•4. Current or past history of a serious illness including, seizures, major psychiatric illness, structural brain disease, liver or kidney failure, organ transplantation, rheumatoid arthritis, uncontrolled hypertension, uncontrolled diabetes or malignancy, cardiovascular event in the last three months.
•5. Alcohol or substance abuse
•6. Allergy or sensitivity to any of the ingredients in the study treatment
•7. Subjects who have participated in other clinical studies during the past 3 months or subjects who intend to participate in other clinical studies parallelly.
•8. Subjects with any other illness or health condition which in the opinion/medical judgement of the study investigator makes the subject ineligible to participate in the study.

发起方